Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. - Burcombe RJ; Makris A; Richman PI; Daley FM; Noble S; Pittam M; Wright D; Allen SA; Dove J; Wilson GD (British journal of cancer, 2005)